← All stocks

10x Genomics, Inc.

TXG Net selling

CIK 0001770787 #1039 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$14.38M

$7.09M on a plan · $0.00 straight out of an exercise

Sold at will

$7.29M

16 of 40 sales

Net

−$14.38M

−$7.29M against sales at will

By person

9 insiders · 41 transactions

111×

Serge Saxonov holds 111 times base salary in stock. $74.84M of shares against $674.25K in salary for 2025.

Salary from the company's own proxy. The shares are what Serge Saxonov last reported holding, valued at $65.26, the price Class A Common Stock was last bought or sold at on the open market here, on 9 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Taich Adam

Chief Financial Officer

—

$4.84M (7) scheduled

−$4.84M

316,344

0.2477%

$20.64M

—

Saxonov Serge

Chief Executive Officer

—

$4.79M (17) scheduled

−$4.79M

1,146,893

0.8982%

$74.84M

+26.6%

STUELPNAGEL JOHN R

Director

—

$2.39M (5)

−$2.39M

328,436

0.2572%

$21.43M

−4.6%

Hindson Benjamin J.

See Remarks

—

$1.46M (4)

−$1.46M

488,182

0.3823%

$31.86M

+41.2%

Teichmann Sarah A.

Director

—

$579.39K (3) scheduled

−$579.39K

28,058

0.0220%

$1.83M

+47.7%

SULIMAN SHEHNAAZ

Director

—

$327.23K (4) scheduled

−$327.23K

29,515

0.0231%

$1.93M

+122.6%

MATEO ALAN

Director

—

85,877

0.0673%

$5.60M

+295.9%

Kosaraju Sridhar

Director

—

65,278

0.0511%

$4.26M

+58.9%

Popovits Kimberly J

Director

—

37,445

0.0293%

$2.44M

+182.4%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 36

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 24

Sales straight out of an exercise 0

Sales at will 16

Transactions with no price 0

Shares from compensation/vesting 463,114

History held since 12 Sep 2019